Present investigation aimed to study plasma BNP hormone estimation as predictor of brain stroke and neurocognitive in relative with other limitations in CKD patient. The case control experimental study was conducted on CKD patient at Yarmuk Hospital at Baghdad Province, Iraq from February to April 2020. The results showed that there were significant variances (P< 0.05) between CKD patients and control group, there was significant increase in BNP hormone and cystatin-C levels at patient, while ihematological parameters were significantly decreased. The parameters of lipid profile were significantly increased (P<0.05). The result revealed that there was relationship between BNP hormone level and CKD. This support that BNP level is related with the renal stage progression in disease. B type natriuretic peptide (BNP) is a beneficial biomarker in the management the failure of heart and brain strokes. The secreted peptides into the circulation after degradation of its originator proBNP and excrete from the kidneys in the active forms or as metabolites.
University of Baghdad
Digital Repository